Clinical Trial Update: Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating synergistic suppression of HSV-1 for fibromyalgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Snippet

Sponsor: Virios Therapeutics, Inc. | Conditions: Fibromyalgia | Phase 2 | Status: COMPLETED